Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer

Table 4 Observed (O) and estimated (E) values of proportion cured and treated, and age standardized disability-adjusted life years (DALYs) per 100,000 population, by cancer in Norway in 2008 derived from observed estimates of the proportion cured and proportion treated, versus expected values derived from models

Cancer sites	Proportion cured (%)		Proportion treated (%)		DALYs^a
Cancer sites	O	E	O	E	O	E
Lip oral cavity	39	33	91	77	46	45
Nasopharynx	39	35	91	81	3	3
Other pharynx	39	39	91	91	32	32
Oesophagus	11	10	52	46	80	79
Stomach	21	34	46	72	149	153
Colorectum	56	50	90	81	658	644
Liver	10	10	30^b	30^b	48	48
Gallbladder	16	38	34	79	34	34
Pancreas	6	5	27^b	27^b	248	248
Larynx	66	48	87	63	21	20
Lung	12	10	17	14	864	860
Melanoma of skin	80	76	95	90	181	180
Kaposi Sarcoma ^c	0	0	0	0	0	0
Breast	76	63	98	81	609	569
Cervix uteri	74	59	87	70	109	101
Corpus uteri	80	71	95	85	88	84
Ovary	35	30	83	72	155	153
Prostate	69	64	79	73	362	351
Testis	96	96	99	99	43	43
Kidney	47	46	80	79	108	108
Bladder	67	62	94	87	105	104
Brain, nervous system	64	26	83	34	282	272
Thyroid	89	89	95	95	11	11
Hodgkin lymphoma	86	90	91	95	11	11
Non-Hodgkin lymphoma	40	37	74	69	134	132
Multiple myeloma	37	34	68	62	66	66
Leukaemia	51	35	47	32	153	152

^aNot discounted with equal age weight.
^bObserved values were used to estimate DALY because inadequate fit of estimated values.
^cIncidence and mortality in Norway from Kaposi Sarcoma was 0.

ISSN: 1471-2288